Prosecution Insights
Last updated: October 02, 2026

Examiner: MORALES, JON ERIC C

Tech Center 3700 • Art Units: 3762 3766 3786 3792 3796

This examiner grants 85% of resolved cases

Analysis

Jon Eric C. Morales is an examiner in Tech Center 3700 and Art Unit 3762, with 1264 resolved cases. His allowance rate is 85.4%, and the median days to allowance is 960. The interview lift is 10.0%, which is a solid benefit for applicants.

With 1264 resolved cases, the data is very reliable. The 85.4% allowance rate indicates a high probability of success. The 960-day median pendency is a standard timeline for this tech center. The 10.0% lift suggests that the examiner is open to interviews and that they can be a useful way to secure an allowance. Practitioners should take advantage of the 85.4% allowance rate and consider the 10.0% lift as a way to ensure their applications move smoothly through the 960-day process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

85.4%
Allow Rate
+15.4% vs TC avg
1,306
Total Applications
+10.0%
Interview Lift
960
Avg Prosecution Days
Based on 1264 resolved cases, 2023–2026

Rejection Statute Breakdown

4.3%
§101 Eligibility
34.8%
§102 Novelty
36.9%
§103 Obviousness
5.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18775498 CIRCULATORY SUPPORT PUMP CENTERING ANCHORING & CENTERING DEVICE Non-Final OA Boston Scientific Scimed, Inc.
18937202 DETERMINING STIMULATION AND SENSING AREAS FOR ADAPTIVE NEUROSTIMULATION TREATMENTS Non-Final OA Boston Scientific Neuromodulation Corporation
18655838 PATIENT- AND CONTEXT-SPECIFIC NEUROMODULATION THERAPY Final Rejection Boston Scientific Neuromodulation Corporation
18839770 INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM Final Rejection NEC Corporation
18847143 SYSTEMS AND METHODS FOR PARAMETERIZING MEDICAL PROCEDURES Final Rejection INTUITIVE SURGICAL OPERATIONS, INC.
18580645 SINGLE FIBER, EXCIMER LASER, LESION CROSSING SYSTEM Final Rejection KONINKLIJKE PHILIPS N.V.
18782349 ENGAGING THE CERVICAL SPINAL CORD CIRCUITRY TO RE-ENABLE VOLITIONAL CONTROL OF HAND FUNCTION IN TETRAPLEGIC SUBJECTS Non-Final OA The Regents of the University of California
18815973 METHOD AND DEVICE FOR CORNEAL CROSS-LINKING WITH REAL-TIME MONITORING Non-Final OA Alcon Inc.
18961962 SYSTEMS AND METHODS TO REDUCE SENSOR INTERFERENCE ASSOCIATED WITH ELECTRICAL THERAPIES Non-Final OA Sage Products, LLC
19062166 INTRAVASCULAR BLOOD PUMP WITH INTAKE FILTER Non-Final OA ABIOMED, INC
18672187 VENTRICULAR ASSIST DEVICE CONTROL Non-Final OA Abiomed Europe GmbH
18833736 DEFIBRILLATOR AND DEFIBRILLATOR MANAGEMENT SYSTEM Final Rejection NIHON KOHDEN CORPORATION
18975845 FOLD FLEX CIRCUIT FOR LNOP Non-Final OA Masimo Corporation
18396958 SYSTEMS AND METHODS FOR OPTIMIZING NERVE STIMULATION THERAPY Final Rejection ElectroCore, Inc.
18950244 PATTERNED STIMULATION INTENSITY FOR NEURAL STIMULATION Non-Final OA Case Western Reserve University
18940723 INTRAVASCULAR BLOOD PUMPS WITH STRUTS AND METHODS OF USE AND MANUFACTURE Non-Final OA Shifamed Holdings, LLC
18245800 TISSUE PIERCING ASSEMBLIES AND METHODS OF USE Non-Final OA SHIFAMED HOLDINGS, LLC
18491328 HIGH-BANDWIDTH SYSTEMS FOR CLOSED-LOOP DEEP BRAIN STIMULATION Non-Final OA PRECISION NEUROSCIENCE CORPORATION
18772597 SYSTEM AND METHOD FOR TREATMENT OF PAIN RELATED TO LIMB JOINT REPLACEMENT SURGERY Final Rejection SPR Therapeutics, Inc.
19017005 METHOD AND APPARATUS FOR TRANSDERMAL STIMULATION OVER THE PALMAR AND PLANTAR SURFACES Non-Final OA EMKinetics, Inc.
18958181 BLOOD PUMP Non-Final OA MAGENTA MEDICAL LTD
18958196 PURGING A BEARING INTERFACE Non-Final OA MAGENTA MEDICAL LTD
18958189 PUMP HEAD DELIVERY Non-Final OA MAGENTA MEDICAL LTD
18958200 IMPELLER Non-Final OA MAGENTA MEDICAL LTD
18442581 OPTICAL MEDICAL EXAMINATION DEVICE Final Rejection HEINE Optotechnik GmbH & Co. KG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month